After trying a dozen different medications, Chris, a Brisbane man who was diagnosed with debilitating Tourette’s Syndrome at age 12, is part of an Australian-first medicinal cannabis trial. For the past 16 years, the condition has impacted all aspects of Chris’ life, including his mental health. This trial has offered Chris more than hope. It’s offered a future.
The Melatonin for Insomnia in Parkinson’s will help to determine whether melatonin should be included in treatment plans for PD patients who suffer from sleep disturbances.
Helping To Find Answers For Motor Neurone Disease Patients: A Novel Antibacterial Treatment Trial Motor Neurone Disease (MND) is a fatal neurodegenerative disease where the
Chris Wright is the first participant to commence a clinical trial of medicinal cannabis as a treatment for the neurological disorder Tourette’s syndrome – a
January 10 marks an important anniversary at Wesley Medical Research for one of our big supporters. On Thursday evening, we reunited some of the committee to celebrate 27 years of making a difference and supporting research.
Every day, 37 people in Australia are diagnosed with Parkinson’s disease. Despite best medical intervention, Parkinson’s patients still have a steady decline in physical function and activity.
Every fortnight, Wayne travels from Kingaroy to Wesley Medical Research to be a part of a multicentre study to evaluate the action and outcomes of a new study drug, compared to the currently available treatment, in the management of patients with late onset Pompe disease.